Skip to main content
L&C BIO Co., Ltd logo

L&C BIO Co., Ltd — Investor Relations & Filings

Ticker · 290650 ISIN · KR7290650001 KO Manufacturing
Open in API
Filings indexed 379 across all filing types
Latest filing 2019-03-05 Regulatory Filings
Country KR South Korea
Listing KO 290650

About L&C BIO Co., Ltd

http://www.lncbio.co.kr/?locale=en_US

L&C BIO Co., Ltd. is a biotechnology company specializing in regenerative medicine. The company develops, manufactures, and commercializes human tissue-based medical devices and allograft treatment materials. Its core operations include the processing, storage, and distribution of human tissues, with a focus on skin, musculoskeletal, and soft tissues, utilizing patented processing technologies. The company's product portfolio also extends to other medical devices and cosmetics. L&C BIO supports its activities through dedicated research and development centers and manufacturing facilities, including a human tissue plant and a pharmaceutical plant, to advance its pipeline and serve global markets.

Recent filings

Filing Released Lang Actions
주주총회집중일개최사유신고
Regulatory Filings Classification · 95% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company is holding its AGM on a date designated as a 'concentrated date' by the KOSDAQ Association. Since this is a specific regulatory disclosure regarding meeting logistics and compliance with corporate governance reporting requirements, and does not fit into the specific categories for AGM materials, proxy statements, or voting results, it is best classified as a general regulatory filing.
2019-03-05 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by L&C Bio. It outlines the date, location, and agenda items (such as approval of financial statements, appointment of directors, and remuneration limits) for the upcoming Annual General Meeting. This type of document is classified as a Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to vote on meeting agenda items.
2019-02-25 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the closure of the shareholder register for the purpose of determining shareholders eligible to vote at the upcoming Annual General Meeting (AGM). It does not contain the full report or proxy materials, but rather serves as a formal regulatory notice of a corporate action. Given it does not fit into specific categories like dividend announcements or share buybacks, it falls under the general regulatory filing category.
2018-12-11 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. It details changes in share ownership by Korea Development Bank and its special related party, KDB Capital, in L&C Bio. This type of filing is a standard regulatory disclosure for significant changes in shareholding (crossing thresholds), which falls under the 'Major Shareholding Notification' category.
2018-12-07 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details changes in share ownership by a specific entity (PCC L&K 1st Fund) in a listed company (L&C Bio). This type of filing is used to notify the market when a shareholder crosses significant ownership thresholds. It does not fit into categories like 'Director's Dealing' (which is for individual insiders) or 'Major Shareholding Notification' (which is the general category for this type of disclosure). Given the specific nature of the Korean regulatory form, it is classified as a Major Shareholding Notification.
2018-12-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 98% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea (DART system) to report changes in shareholdings by insiders or major shareholders. Based on the provided categories, this falls under 'Major Shareholding Notification' (MRQ) as it details the change in ownership percentage of a major shareholder (PCC L&K 1st Fund) in the issuer (L&C Bio).
2018-12-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.